Cargando…

The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1

Purpose: Aloin (ALO), a bioactive ingredient extracted from aloe vera, has anti-tumor effects. High Mobility Group Box 1 (HMGB1), a highly conserved nuclear DNA-binding protein, has been implicated in various cancer types. Highly expressed HMGB1 is closely associated with tumor cells apoptosis, prol...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Hong, Tang, Tuo, Wang, Shengnan, Wang, Ziqian, Ma, Yunfei, Cai, Tianyu, Cheng, Xiuliang, Qi, Shimei, Zhang, Yao, Qi, Zhilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489572/
https://www.ncbi.nlm.nih.gov/pubmed/31114162
http://dx.doi.org/10.2147/DDDT.S201818
_version_ 1783414845406707712
author Tao, Hong
Tang, Tuo
Wang, Shengnan
Wang, Ziqian
Ma, Yunfei
Cai, Tianyu
Cheng, Xiuliang
Qi, Shimei
Zhang, Yao
Qi, Zhilin
author_facet Tao, Hong
Tang, Tuo
Wang, Shengnan
Wang, Ziqian
Ma, Yunfei
Cai, Tianyu
Cheng, Xiuliang
Qi, Shimei
Zhang, Yao
Qi, Zhilin
author_sort Tao, Hong
collection PubMed
description Purpose: Aloin (ALO), a bioactive ingredient extracted from aloe vera, has anti-tumor effects. High Mobility Group Box 1 (HMGB1), a highly conserved nuclear DNA-binding protein, has been implicated in various cancer types. Highly expressed HMGB1 is closely associated with tumor cells apoptosis, proliferation and migration. We investigated the specific molecular mechanisms by which ALO-induced apoptosis by targeting HMGB1 in gastric cancer cells. Materials and methods: Human gastric cancer HGC-27 cells were treated with different doses of ALO (100, 200 and 400 µg/ml) for 24 h, after which DAPI staining was used to observe the nuclear morphology, Annexin V/PI double staining assay was used to determine the rate of apoptosis; Western blotting was used to detect the levels of PARP, pro-caspase3, HMGB1 and RAGE; nuclear translocation of HMGB1 was determined by conducting a nucleoplasm separation experiment. The Enzyme linked immunosorbent assay (ELISA) assay was used to detect release of HMGB1. The HGC-27 cells, transfected with HMGB1 shRNA plasmids, were stimulated with ALO for 24 h, after which a flow cytometry assay was used to detect the rate of apoptosis. HGC-27 cells were pre-treated with or without ALO and then stimulated with rhHMGB1, the phosphorylation of Akt, mTOR, P70S6K, S6, 4EBP1, ERK, P90RSK, cAMP regulatory element binding (CREB) were detected by Western blotting. Results: After different doses of ALO treatment, the nuclei showed morphological changes characteristic of apoptosis. Apoptotic rates were enhanced in a dose dependent manner. The level of cleaved PARP was enhanced and pro-caspase3, HMGB1 and RAGE levels were reduced, HMGB1 nuclear translocation and release were inhibited. The activation of rhHMGB1-induced Akt-mTOR-P70S6K and ERK-CREB signalling pathways was inhibited by ALO. Blocking these signalling pathways by special inhibitors and HMGB1 knockdown could enhance ALO-induced HGC-27 cell apoptosis. Conclusion: ALO- induced HGC-27 cell apoptosis by down-regulating expressions of HMGB1 and RAGE, inhibiting HMGB1 release and then suppressing rhHMGB1-induced activation of Akt-mTOR-P70S6K and ERK-P90RSK-CREB signalling pathways.
format Online
Article
Text
id pubmed-6489572
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-64895722019-05-21 The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1 Tao, Hong Tang, Tuo Wang, Shengnan Wang, Ziqian Ma, Yunfei Cai, Tianyu Cheng, Xiuliang Qi, Shimei Zhang, Yao Qi, Zhilin Drug Des Devel Ther Original Research Purpose: Aloin (ALO), a bioactive ingredient extracted from aloe vera, has anti-tumor effects. High Mobility Group Box 1 (HMGB1), a highly conserved nuclear DNA-binding protein, has been implicated in various cancer types. Highly expressed HMGB1 is closely associated with tumor cells apoptosis, proliferation and migration. We investigated the specific molecular mechanisms by which ALO-induced apoptosis by targeting HMGB1 in gastric cancer cells. Materials and methods: Human gastric cancer HGC-27 cells were treated with different doses of ALO (100, 200 and 400 µg/ml) for 24 h, after which DAPI staining was used to observe the nuclear morphology, Annexin V/PI double staining assay was used to determine the rate of apoptosis; Western blotting was used to detect the levels of PARP, pro-caspase3, HMGB1 and RAGE; nuclear translocation of HMGB1 was determined by conducting a nucleoplasm separation experiment. The Enzyme linked immunosorbent assay (ELISA) assay was used to detect release of HMGB1. The HGC-27 cells, transfected with HMGB1 shRNA plasmids, were stimulated with ALO for 24 h, after which a flow cytometry assay was used to detect the rate of apoptosis. HGC-27 cells were pre-treated with or without ALO and then stimulated with rhHMGB1, the phosphorylation of Akt, mTOR, P70S6K, S6, 4EBP1, ERK, P90RSK, cAMP regulatory element binding (CREB) were detected by Western blotting. Results: After different doses of ALO treatment, the nuclei showed morphological changes characteristic of apoptosis. Apoptotic rates were enhanced in a dose dependent manner. The level of cleaved PARP was enhanced and pro-caspase3, HMGB1 and RAGE levels were reduced, HMGB1 nuclear translocation and release were inhibited. The activation of rhHMGB1-induced Akt-mTOR-P70S6K and ERK-CREB signalling pathways was inhibited by ALO. Blocking these signalling pathways by special inhibitors and HMGB1 knockdown could enhance ALO-induced HGC-27 cell apoptosis. Conclusion: ALO- induced HGC-27 cell apoptosis by down-regulating expressions of HMGB1 and RAGE, inhibiting HMGB1 release and then suppressing rhHMGB1-induced activation of Akt-mTOR-P70S6K and ERK-P90RSK-CREB signalling pathways. Dove 2019-04-17 /pmc/articles/PMC6489572/ /pubmed/31114162 http://dx.doi.org/10.2147/DDDT.S201818 Text en © 2019 Tao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tao, Hong
Tang, Tuo
Wang, Shengnan
Wang, Ziqian
Ma, Yunfei
Cai, Tianyu
Cheng, Xiuliang
Qi, Shimei
Zhang, Yao
Qi, Zhilin
The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
title The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
title_full The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
title_fullStr The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
title_full_unstemmed The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
title_short The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
title_sort molecular mechanisms of aloin induce gastric cancer cells apoptosis by targeting high mobility group box 1
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489572/
https://www.ncbi.nlm.nih.gov/pubmed/31114162
http://dx.doi.org/10.2147/DDDT.S201818
work_keys_str_mv AT taohong themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT tangtuo themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT wangshengnan themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT wangziqian themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT mayunfei themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT caitianyu themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT chengxiuliang themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT qishimei themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT zhangyao themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT qizhilin themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT taohong molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT tangtuo molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT wangshengnan molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT wangziqian molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT mayunfei molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT caitianyu molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT chengxiuliang molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT qishimei molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT zhangyao molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1
AT qizhilin molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1